BIO-REFERENCE LABS INC's ticker is BRLI and the CUSIP is 09057G602. A total of 182 filers reported holding BIO-REFERENCE LABS INC in Q2 2013. The put-call ratio across all filers is 0.16 and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Murphy Michael R | 818,246 | $28,835,000 | 11.11% |
| RK Asset Management, LLC | 352,798 | $12,433,000 | 9.67% |
| TANAKA CAPITAL MANAGEMENT INC | 46,830 | $1,650,000 | 4.56% |
| AMERICAN CAPITAL MANAGEMENT INC | 376,860 | $13,281,000 | 1.31% |
| Smith, Graham & Co., Investment Advisors, LP | 221,587 | $7,809,000 | 1.06% |
| RIVERBRIDGE PARTNERS LLC | 1,361,659 | $47,985,000 | 0.86% |
| Granite Investment Partners, LLC | 273,007 | $9,621,000 | 0.83% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 203,000 | $7,154,000 | 0.75% |
| Boston Trust Walden Corp | 1,288,615 | $45,411,000 | 0.67% |
| NEW AMSTERDAM PARTNERS LLC/NY | 137,335 | $4,840,000 | 0.39% |